{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:16:03Z","timestamp":1771330563025,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-026-02057-5","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T10:54:18Z","timestamp":1769252058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell transcriptomics uncover RNF130-mediated TNF-\u03b1 pathway activation and worenine synergy with paclitaxel in breast cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Mi","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangbin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"issue":"7796","key":"2057_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41586-019-1876-x","volume":"578","author":"HW Jackson","year":"2020","unstructured":"Jackson HW, Fischer JR, Zanotelli VRT, Ali HR, Mechera R, Soysal SD, Moch H, Muenst S, Varga Z, Weber WP, et al. The single-cell pathology landscape of breast cancer. Nature. 2020;578(7796):615\u2013. https:\/\/doi.org\/10.1038\/s41586-019-1876-x.","journal-title":"Nature"},{"issue":"1","key":"2057_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13058-020-01353-z","volume":"22","author":"TP Reddy","year":"2020","unstructured":"Reddy TP, Rosato RR, Li XX, Moulder S, Piwnica-Worms H, Chang JC. A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations. Breast Cancer Res. 2020;22(1):11. https:\/\/doi.org\/10.1186\/s13058-020-01353-z.","journal-title":"Breast Cancer Res"},{"issue":"10074","key":"2057_CR3","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/s0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck N, Gnant M, Breast cancer. Lancet. 2017;389(10074):1134\u201350. https:\/\/doi.org\/10.1016\/s0140-6736(16)31891-8.","journal-title":"Lancet"},{"issue":"1","key":"2057_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.canlet.2016.03.001","volume":"382","author":"G Judes","year":"2016","unstructured":"Judes G, Rifa\u00ef K, Daures M, Dubois L, Bignon YJ, Penault-Llorca F, Bernard-Gallon D. High-throughput omics technologies: new tools for the study of triple-negative breast cancer. Cancer Lett. 2016;382(1):77\u201385. https:\/\/doi.org\/10.1016\/j.canlet.2016.03.001.","journal-title":"Cancer Lett"},{"issue":"8","key":"2057_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41568-020-0266-x","volume":"20","author":"KL Britt","year":"2020","unstructured":"Britt KL, Cuzick J, Phillips KA. Key steps for effective breast cancer prevention. Nat Rev Cancer. 2020;20(8):417\u201336. https:\/\/doi.org\/10.1038\/s41568-020-0266-x.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2057_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41568-023-00604-3","volume":"23","author":"M Will","year":"2023","unstructured":"Will M, Liang JC, Metcalfe C, Chandarlapaty S. Therapeutic resistance to anti-oestrogen therapy in breast cancer. Nat Rev Cancer. 2023;23(10):673\u201385. https:\/\/doi.org\/10.1038\/s41568-023-00604-3.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2057_CR7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","volume":"37","author":"AB Hanker","year":"2020","unstructured":"Hanker AB, Sudhan DR, Arteaga CL. Overcoming endocrine resistance in breast cancer. Cancer Cell. 2020;37(4):496\u2013513. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.009.","journal-title":"Cancer Cell"},{"issue":"1","key":"2057_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s43556-022-00071-6","volume":"3","author":"RN Yang","year":"2022","unstructured":"Yang RN, Li YY, Wang H, Qin TL, Yin XM, Ma XL. Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy. Mol Biomed. 2022;3(1):18. https:\/\/doi.org\/10.1186\/s43556-022-00071-6.","journal-title":"Mol Biomed"},{"issue":"3","key":"2057_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.20517\/cdr.2021.04","volume":"4","author":"Y Zong","year":"2021","unstructured":"Zong Y, Pegram M. Research advances and new challenges in overcoming triple-negative breast cancer. Cancer Drug Resist. 2021;4(3):517\u201342. https:\/\/doi.org\/10.20517\/cdr.2021.04.","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"2057_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41467-022-33598-x","volume":"13","author":"L Monteran","year":"2022","unstructured":"Monteran L, Ershaid N, Doron H, Zait Y, Scharff Y, Ben-Yosef S, Avivi C, Barshack I, Sonnenblick A, Erez N. Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer. Nat Commun. 2022;13(1):19. https:\/\/doi.org\/10.1038\/s41467-022-33598-x.","journal-title":"Nat Commun"},{"key":"2057_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj-2022-071674","volume":"381","author":"RA Leon-Ferre","year":"2023","unstructured":"Leon-Ferre RA, Goetz MP. Advances in systemic therapies for triple negative breast cancer. Bmj-British Med J. 2023;381:15. https:\/\/doi.org\/10.1136\/bmj-2022-071674.","journal-title":"Bmj-British Med J"},{"issue":"2","key":"2057_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.Cd-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment. Cancer Discov. 2019;9(2):176\u201398. https:\/\/doi.org\/10.1158\/2159-8290.Cd-18-1177.","journal-title":"Cancer Discov"},{"issue":"7","key":"2057_CR13","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1016\/j.apsb.2023.05.006","volume":"13","author":"JN Zhang","year":"2023","unstructured":"Zhang JN, Zhang Z, Huang ZL, Li ML, Yang F, Wu ZQ, Guo Q, Mei XY, Lu B, Wang CH, et al. Isotoosendanin exerts Inhibition on triple- negative breast cancer through abrogating tgf-13-induced epithelial-mesenchymal transition\u2009<\u2009i\u2009>\u2009via\u2009directly targeting tgfi3r1. Acta Pharm Sinica B. 2023;13(7):2990\u20133007. https:\/\/doi.org\/10.1016\/j.apsb.2023.05.006.","journal-title":"Acta Pharm Sinica B"},{"key":"2057_CR14","doi-asserted-by":"publisher","unstructured":"Tripathi D, Davies NM, Rajinikanth PS, Pandey P. Advancements in targeted therapies and pharmacogenomics for personalized breast cancer treatment: the role of gene Snps in treatment resistance. Curr Gene Ther. 2025;35. https:\/\/doi.org\/10.2174\/0115665232373621250618181424.","DOI":"10.2174\/0115665232373621250618181424"},{"issue":"3","key":"2057_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/0109298665339026250114070523","volume":"32","author":"X Li","year":"2025","unstructured":"Li X, Liu J, He LL, Tian M, Xu YY, Peng B. Mir-584-5p regulates msmo1 to modulate the akt\/pi3k pathway and inhibit breast cancer progression. Protein Pept Lett. 2025;32(3):171\u201382. https:\/\/doi.org\/10.2174\/0109298665339026250114070523.","journal-title":"Protein Pept Lett"},{"issue":"1","key":"2057_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-021-01223-x","volume":"15","author":"HY Li","year":"2022","unstructured":"Li HY, Yang PH, Wang JH, Zhang J, Ma QY, Jiang YJ, Wu YN, Han T, Xiang DM. Hlf regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk. J Hematol Oncol. 2022;15(1):6. https:\/\/doi.org\/10.1186\/s13045-021-01223-x.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2057_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13045-022-01260-0","volume":"15","author":"MR Liao","year":"2022","unstructured":"Liao MR, Qin R, Huang W, Zhu HP, Peng F, Han B, Liu B. Targeting regulated cell death (rcd) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies. J Hematol Oncol. 2022;15(1):44. https:\/\/doi.org\/10.1186\/s13045-022-01260-0.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2057_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41467-023-36325-2","volume":"14","author":"T Hirz","year":"2023","unstructured":"Hirz T, Mei SL, Sarkar H, Kfoury Y, Wu SL, Verhoeven BM, Subtelny AO, Zlatev DV, Wszolek MW, Salari K, et al. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Nat Commun. 2023;14(1):20. https:\/\/doi.org\/10.1038\/s41467-023-36325-2.","journal-title":"Nat Commun"},{"key":"2057_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.semcancer.2019.07.024","volume":"60","author":"F Orso","year":"2020","unstructured":"Orso F, Quirico L, Dettori D, Coppo R, Virga F, Ferreira LC, Paoletti C, Baruffaldi D, Penna E, Taverna D. Role of Mirnas in tumor and endothelial cell interactions during tumor progression. Sem Cancer Biol. 2020;60:214\u201324. https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.024.","journal-title":"Sem Cancer Biol"},{"issue":"7835","key":"2057_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41586-020-2922-4","volume":"587","author":"KJ Travaglini","year":"2020","unstructured":"Travaglini KJ, Nabhan AN, Penland L, Sinha R, Gillich A, Sit RV, Chang S, Conley SD, Mori Y, Seita J, et al. A molecular cell atlas of the human lung from single-cell Rna sequencing. Nature. 2020;587(7835):37. https:\/\/doi.org\/10.1038\/s41586-020-2922-4.","journal-title":"Nature"},{"issue":"6","key":"2057_CR21","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ccell.2021.05.002","volume":"39","author":"T Hara","year":"2021","unstructured":"Hara T, Chanoch-Myers R, Mathewson ND, Myskiw C, Atta L, Bussema L, Eichhorn SW, Greenwald AC, Kinker GS, Rodman C, et al. Interactions between cancer cells and immune cells drive transitions to mesenchymal-like States in glioblastoma. Cancer Cell. 2021;39(6):779\u2013. https:\/\/doi.org\/10.1016\/j.ccell.2021.05.002.","journal-title":"Cancer Cell"},{"issue":"4","key":"2057_CR22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cell.2018.03.041","volume":"173","author":"C Kim","year":"2018","unstructured":"Kim C, Gao RL, Sei E, Brandt R, Hartman J, Hatschek T, Crosetto N, Foukakis T, Navin NE. Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell. 2018;173(4):879\u2013. https:\/\/doi.org\/10.1016\/j.cell.2018.03.041.","journal-title":"Cell"},{"issue":"2","key":"2057_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jhep.2023.03.039","volume":"79","author":"KP Jin","year":"2023","unstructured":"Jin KP, Shi YZ, Zhang HT, Zhangyuan GY, Wang F, Li S, Chen C, Zhang JY, Wang H, Zhang WJ, et al. A tnf\u03b1\/miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis. J Hepatol. 2023;79(2):403\u201316. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.039.","journal-title":"J Hepatol"},{"key":"2057_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41419-017-0177-2","volume":"9","author":"QY Yang","year":"2018","unstructured":"Yang QY, Lin WR, Liu ZW, Zhu JB, Huang N, Cui ZQ, Han ZP, Pan QH, Goel A, Sun FY. Rap80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinoma. Cell Death Dis. 2018;9:14. https:\/\/doi.org\/10.1038\/s41419-017-0177-2.","journal-title":"Cell Death Dis"},{"issue":"12","key":"2057_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","volume":"23","author":"G Dewson","year":"2023","unstructured":"Dewson G, Eichhorn PJA, Komander D. Deubiquitinases in cancer. Nat Rev Cancer. 2023;23(12):842\u201362. https:\/\/doi.org\/10.1038\/s41568-023-00633-y.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2057_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41580-022-00543-1","volume":"24","author":"I Dikic","year":"2023","unstructured":"Dikic I, Schulman BA. An expanded lexicon for the ubiquitin code. Nat Rev Mol Cell Biol. 2023;24(4):273\u201387. https:\/\/doi.org\/10.1038\/s41580-022-00543-1.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"2057_CR27","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/cac2.12192","volume":"41","author":"FY Ji","year":"2021","unstructured":"Ji FY, Zhou MH, Sun ZY, Jiang ZY, Zhu HH, Xie ZY, Ouyang XX, Zhang LJ, Li LJ. Integrative proteomics reveals the role of e3 ubiquitin ligase syvn1 in hepatocellular carcinoma metastasis. Cancer Commun. 2021;41(10):1007\u201323. https:\/\/doi.org\/10.1002\/cac2.12192.","journal-title":"Cancer Commun"},{"key":"2057_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.semcancer.2022.11.002","volume":"87","author":"WJ Wang","year":"2022","unstructured":"Wang WJ, Liu WJ, Chen QL, Yuan Y, Wang PT. Targeting csc-related transcription factors by e3 ubiquitin ligases for cancer therapy. Sem Cancer Biol. 2022;87:84\u201397. https:\/\/doi.org\/10.1016\/j.semcancer.2022.11.002.","journal-title":"Sem Cancer Biol"},{"key":"2057_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.semcancer.2022.06.004","volume":"86","author":"JX Liu","year":"2022","unstructured":"Liu JX, Chen T, Li SZ, Liu WJ, Wang PT, Shang GN. Targeting matrix metalloproteinases by e3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy. Sem Cancer Biol. 2022;86:259\u201368. https:\/\/doi.org\/10.1016\/j.semcancer.2022.06.004.","journal-title":"Sem Cancer Biol"},{"issue":"7","key":"2057_CR30","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/circresaha.122.321938","volume":"132","author":"BL Clifford","year":"2023","unstructured":"Clifford BL, Jarrett KE, Cheng J, Cheng AEL, Seldin M, Morand P, Lee RC, Chen MRY, Baldan A, Vallim TQD, et al. Rnf130 regulates Ldlr availability and plasma Ldl cholesterol levels. Circul Res. 2023;132(7):849\u201363. https:\/\/doi.org\/10.1161\/circresaha.122.321938.","journal-title":"Circul Res"},{"issue":"9","key":"2057_CR31","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, Thennavan A, Wang CF, Torpy JR, Bartonicek N, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53(9):1334\u2013. https:\/\/doi.org\/10.1038\/s41588-021-00911-1.","journal-title":"Nat Genet"},{"issue":"11","key":"2057_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.15252\/embj.2020107333","volume":"40","author":"B Pal","year":"2021","unstructured":"Pal B, Chen YS, Vaillant F, Capaldo BD, Joyce R, Song XY, Bryant VL, Penington JS, Di Stefano L, Ribera NT, et al. A single-cell Rna expression atlas of normal, preneoplastic and tumorigenic States in the human breast. EMBO J. 2021;40(11):23. https:\/\/doi.org\/10.15252\/embj.2020107333.","journal-title":"EMBO J"},{"issue":"2","key":"2057_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.isci.2024.108896","volume":"27","author":"XS Wang","year":"2024","unstructured":"Wang XS, Zhou Y, Wu ZG, Xie C, Xu WQ, Zhou QT, Yang DH, Zhu D, Wang MW, Wang L. Single-cell transcriptomics reveals the role of antigen presentation in liver metastatic breast cancer. Iscience. 2024;27(2):20. https:\/\/doi.org\/10.1016\/j.isci.2024.108896.","journal-title":"Iscience"},{"key":"2057_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejca.2023.113371","volume":"195","author":"NM Atallah","year":"2023","unstructured":"Atallah NM, Haque M, Quinn C, Toss MS, Makhlouf S, Ibrahim A, Green AR, Alsaleem M, Rutland CS, Allegrucci C, et al. Characterisation of luminal and triple-negative breast cancer with her2 low protein expression. Eur J Cancer. 2023;195:13. https:\/\/doi.org\/10.1016\/j.ejca.2023.113371.","journal-title":"Eur J Cancer"},{"key":"2057_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2407-11-143","volume":"11","author":"KJ Kao","year":"2011","unstructured":"Kao KJ, Chang KM, Hsu HC, Huang AT. Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization. BMC Cancer. 2011;11:15. https:\/\/doi.org\/10.1186\/1471-2407-11-143.","journal-title":"BMC Cancer"},{"issue":"1","key":"2057_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/jitc-2019-000416","volume":"8","author":"J Rios-Doria","year":"2020","unstructured":"Rios-Doria J, Stevens C, Maddage C, Lasky K, Koblish HK. Characterization of human cancer xenografts in humanized mice. J Immunother Cancer. 2020;8(1):8. https:\/\/doi.org\/10.1136\/jitc-2019-000416.","journal-title":"J Immunother Cancer"},{"issue":"8","key":"2057_CR37","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.7150\/thno.53412","volume":"11","author":"B Chen","year":"2021","unstructured":"Chen B, Sang YT, Song XJ, Zhang D, Wang LJ, Zhao WJ, Liang YR, Zhang N, Yang QF. Exosomal mir-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting usp28. Theranostics. 2021;11(8):3932\u201347. https:\/\/doi.org\/10.7150\/thno.53412.","journal-title":"Theranostics"},{"key":"2057_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12885-015-1546-9","volume":"15","author":"M Genin","year":"2015","unstructured":"Genin M, Clement F, Fattaccioli A, Raes M, Michiels C. M1 and m2 macrophages derived from thp-1 cells differentially modulate the response of cancer cells to Etoposide. BMC Cancer. 2015;15:14. https:\/\/doi.org\/10.1186\/s12885-015-1546-9.","journal-title":"BMC Cancer"},{"issue":"1","key":"2057_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41598-024-73394-9","volume":"14","author":"LJ Hong","year":"2024","unstructured":"Hong LJ, Tanaka M, Yasui M, Hara-Chikuma M. Hsp90 promotes tumor associated macrophage differentiation during triple-negative breast cancer progression. Sci Rep. 2024;14(1):11. https:\/\/doi.org\/10.1038\/s41598-024-73394-9.","journal-title":"Sci Rep"},{"issue":"10","key":"2057_CR40","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.15252\/embr.201540974","volume":"16","author":"PA Cassar","year":"2015","unstructured":"Cassar PA, Carpenedo RL, Samavarchi-Tehrani P, Olsen JB, Park CJ, Chang WY, Chen ZY, Choey C, Delaney S, Guo HS, et al. Integrative genomics positions mkrn1 as a novel ribonucleoprotein within the embryonic stem cell gene regulatory network. EMBO Rep. 2015;16(10):1334\u201357. https:\/\/doi.org\/10.15252\/embr.201540974.","journal-title":"EMBO Rep"},{"issue":"12","key":"2057_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/jvi.00393-17","volume":"91","author":"T Deschamps","year":"2017","unstructured":"Deschamps T, Dogrammatzis C, Mullick R, Kalamvoki M. Cbl e3 ligase mediates the removal of nectin-1 from the surface of herpes simplex virus 1-infected cells. J Virol. 2017;91(12):14. https:\/\/doi.org\/10.1128\/jvi.00393-17.","journal-title":"J Virol"},{"key":"2057_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7554\/eLife.33126","volume":"7","author":"AM Lebensohn","year":"2018","unstructured":"Lebensohn AM, Rohatgi R. R-spondins can potentiate Wnt signaling without Lgrs. Elife. 2018;7:18. https:\/\/doi.org\/10.7554\/eLife.33126.","journal-title":"Elife"},{"issue":"12","key":"2057_CR43","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1900925","volume":"204","author":"SJ Meyer","year":"2020","unstructured":"Meyer SJ, Boser A, Korn MA, Koller C, Bertocci B, Reimann L, Warscheid B, Nitschke L. Cullin 3 is crucial for pro-b cell proliferation, interacts with cd22, and controls cd22 internalization on b cells. J Immunol. 2020;204(12):3360\u201374. https:\/\/doi.org\/10.4049\/jimmunol.1900925.","journal-title":"J Immunol"},{"key":"2057_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fimmu.2013.00472","volume":"4","author":"D Vucic","year":"2013","unstructured":"Vucic D. The role of ubiquitination in tweak-stimulated signaling. Front Immunol. 2013;4:7. https:\/\/doi.org\/10.3389\/fimmu.2013.00472.","journal-title":"Front Immunol"},{"issue":"3","key":"2057_CR45","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/jcp.20254","volume":"203","author":"WY Lui","year":"2005","unstructured":"Lui WY, Lee WM. Camp perturbs inter-sertoli tight junction permeability barrier in vitro via its effect on proteasome-sensitive ubiquitination of occludin. J Cell Physiol. 2005;203(3):564\u201372. https:\/\/doi.org\/10.1002\/jcp.20254.","journal-title":"J Cell Physiol"},{"issue":"16","key":"2057_CR46","doi-asserted-by":"publisher","first-page":"7323","DOI":"10.1073\/pnas.0915075107","volume":"107","author":"K Janssens","year":"2010","unstructured":"Janssens K, Sung HH, Rorth P. Direct detection of guidance receptor activity during border cell migration. Proc Natl Acad Sci USA. 2010;107(16):7323\u20138. https:\/\/doi.org\/10.1073\/pnas.0915075107.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2057_CR47","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1182\/blood.2022016580","volume":"141","author":"HX Chen","year":"2023","unstructured":"Chen HX, Bai YP, Kobayashi M, Xiao SY, Cai WJ, Barajas S, Chen SS, Miao JM, Meke FN, Vemula S, et al. Prl2 phosphatase enhances oncogenic flt3 signaling via dephosphorylation of the e3 ubiquitin ligase Cbl at tyrosine 371. Blood. 2023;141(3):244\u201359. https:\/\/doi.org\/10.1182\/blood.2022016580.","journal-title":"Blood"},{"issue":"3","key":"2057_CR48","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1002\/jcp.29156","volume":"235","author":"J Liu","year":"2020","unstructured":"Liu J, Yao QY, Xiao L, Li F, Ma W, Zhang ZH, Xie XY, Yang CM, Cui Q, Tian Y, et al. Apc\/cdh1 targets pecam-1 for ubiquitination and degradation in endothelial cells. J Cell Physiol. 2020;235(3):2521\u201331. https:\/\/doi.org\/10.1002\/jcp.29156.","journal-title":"J Cell Physiol"},{"issue":"2","key":"2057_CR49","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.stem.2016.04.002","volume":"19","author":"C Dominguez-Brauer","year":"2016","unstructured":"Dominguez-Brauer C, Hao ZY, Elia AJ, Fortin JM, Nechanitzky R, Brauer PM, Sheng Y, Mana MD, Chio IIC, Haight J, et al. Mule regulates the intestinal stem cell niche via the Wnt pathway and targets ephb3 for proteasomal and lysosomal degradation. Cell Stem Cell. 2016;19(2):205\u201316. https:\/\/doi.org\/10.1016\/j.stem.2016.04.002.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"2057_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1073\/pnas.2309902121","volume":"121","author":"M Borettoa","year":"2024","unstructured":"Borettoa M, Geurtsa MH, Gandhia S, Mac ZL, Staliarovae N, Celottia M, Lima S, Hea GW, Millena R, Driehuisa E, et al. Epidermal growth factor receptor (egfr) is a target of the tumor-suppressor e3 ligase fbxw7. Proc Natl Acad Sci USA. 2024;121(12):12. https:\/\/doi.org\/10.1073\/pnas.2309902121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2057_CR51","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.2147\/dddt.S319786","volume":"15","author":"JQ Liu","year":"2021","unstructured":"Liu JQ, Liu J, Tong XL, Peng WJ, Wei SS, Sun TL, Wang YK, Zhang BK, Li WQ. Network Pharmacology prediction and molecular docking-based strategy to discover the potential Pharmacological mechanism of Huai Hua San against ulcerative colitis. Drug Des Dev Therapy. 2021;15:3255\u201376. https:\/\/doi.org\/10.2147\/dddt.S319786.","journal-title":"Drug Des Dev Therapy"},{"key":"2057_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jep.2022.115799","volume":"301","author":"Y Lin","year":"2023","unstructured":"Lin Y, Chen XJ, He L, Yan XL, Li QR, Zhang X, He MH, Chang S, Tu B, Long QD, et al. Systematic Elucidation of the bioactive alkaloids and potential mechanism from sophora flavescens for the treatment of eczema via network Pharmacology. J Ethnopharmacol. 2023;301:10. https:\/\/doi.org\/10.1016\/j.jep.2022.115799.","journal-title":"J Ethnopharmacol"},{"key":"2057_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fnagi.2022.890046","volume":"14","author":"XW Ye","year":"2022","unstructured":"Ye XW, Wang HL, Cheng SQ, Xia LJ, Xu XF, Li XR. Network pharmacology-based strategy to investigate the Pharmacologic mechanisms of coptidis rhizoma for the treatment of alzheimer\u2019s disease. Front Aging Neurosci. 2022;14:19. https:\/\/doi.org\/10.3389\/fnagi.2022.890046.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"2057_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41598-024-80101-1","volume":"14","author":"YW Hua","year":"2024","unstructured":"Hua YW, Tan X, Zhang JW, Xu NC, Chen RE, Zhou SQ, Liu SQ, Li K, Chen WY, Luo QL, et al. Deciphering the Pharmacological mechanism of radix astragali for allergic rhinitis through network Pharmacology and experimental validation. Sci Rep. 2024;14(1):15. https:\/\/doi.org\/10.1038\/s41598-024-80101-1.","journal-title":"Sci Rep"},{"issue":"3","key":"2057_CR55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2174\/1566523221666210907162005","volume":"22","author":"XH Li","year":"2022","unstructured":"Li XH, Xiang L, Lin Y, Tang Q, Meng FB, Chen W. Computational analysis illustrates the mechanism of Qingfei Paidu Decoction in blocking the transition of covid-19 patients from mild to severe stage. Curr Gene Ther. 2022;22(3):277\u201389. https:\/\/doi.org\/10.2174\/1566523221666210907162005.","journal-title":"Curr Gene Ther"},{"key":"2057_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"JL Ru","year":"2014","unstructured":"Ru JL, Li P, Wang JN, Zhou W, Li BH, Huang C, Li PD, Guo ZH, Tao WY, Yang YF, et al. Tcmsp: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:6. https:\/\/doi.org\/10.1186\/1758-2946-6-13.","journal-title":"J Cheminform"},{"issue":"1","key":"2057_CR57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41416-021-01516-5","volume":"126","author":"M Mondal","year":"2022","unstructured":"Mondal M, Conole D, Nautiyal J, Tate EW. Uchl1 as a novel target in breast cancer: emerging insights from cell and chemical biology. Br J Cancer. 2022;126(1):24\u201333. https:\/\/doi.org\/10.1038\/s41416-021-01516-5.","journal-title":"Br J Cancer"},{"issue":"8","key":"2057_CR58","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris MA, Savas P, Virassamy B, O\u2019Malley MMR, Kay J, Mueller SN, Mackay LK, Salgado R, Loi S. Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer. 2024;24(8):554\u201377. https:\/\/doi.org\/10.1038\/s41568-024-00714-6.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2057_CR59","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cmet.2022.02.010","volume":"34","author":"H Wang","year":"2022","unstructured":"Wang H, Rong XY, Zhao G, Zhou YF, Xiao Y, Ma D, Jin X, Wu YL, Yan YC, Yang H, et al. The microbial metabolite trimethylamine n-oxide promotes antitumor immunity in triple-negative breast cancer. Cell Metabol. 2022;34(4):581\u2013. https:\/\/doi.org\/10.1016\/j.cmet.2022.02.010.","journal-title":"Cell Metabol"},{"issue":"1","key":"2057_CR60","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12282-022-01400-x","volume":"30","author":"N Liao","year":"2023","unstructured":"Liao N, Li C, Cao L, Chen YH, Ren CY, Chen XQ, Mok HP, Wen LZ, Li K, Wang YL, et al. Single-cell profile of tumor and immune cells in primary breast cancer, Sentinel lymph node, and metastatic lymph node. Breast Cancer. 2023;30(1):77\u201387. https:\/\/doi.org\/10.1007\/s12282-022-01400-x.","journal-title":"Breast Cancer"},{"issue":"6","key":"2057_CR61","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.isci.2024.109902","volume":"27","author":"H Jin","year":"2024","unstructured":"Jin H, Chen Y, Zhang DB, Lin JF, Huang SY, Wu XH, Deng W, Huang JD, Yao YD. Ythdf2 favors protumoral macrophage polarization and implies poor survival outcomes in triple negative breast cancer. Iscience. 2024;27(6):20. https:\/\/doi.org\/10.1016\/j.isci.2024.109902.","journal-title":"Iscience"},{"key":"2057_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","volume":"60","author":"YR Liang","year":"2020","unstructured":"Liang YR, Zhang HW, Song XJ, Yang QF. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Sem Cancer Biol. 2020;60:14\u201327. https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.012.","journal-title":"Sem Cancer Biol"},{"issue":"9","key":"2057_CR63","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1039\/d2cs00148a","volume":"51","author":"I Sosic","year":"2022","unstructured":"Sosic I, Bricelj A, Steinebach C. E3 ligase ligand chemistries: from Building blocks to protein degraders. Chem Soc Rev. 2022;51(9):3487\u2013534. https:\/\/doi.org\/10.1039\/d2cs00148a.","journal-title":"Chem Soc Rev"},{"issue":"5","key":"2057_CR64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/0113892029255941231014142050","volume":"24","author":"J Qiu","year":"2023","unstructured":"Qiu J, Zhou T, Wang DH, Hong WM, Qian D, Meng XL, Liu XZ. Pan-cancer analysis identifies aimp2 as a potential biomarker for breast cancer. Curr Genom. 2023;24(5):307\u201329. https:\/\/doi.org\/10.2174\/0113892029255941231014142050.","journal-title":"Curr Genom"},{"key":"2057_CR65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.phrs.2021.105728","volume":"170","author":"S Wang","year":"2021","unstructured":"Wang S, Fu JL, Hao HF, Jiao YN, Li PP, Han SY. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol Res. 2021;170:11. https:\/\/doi.org\/10.1016\/j.phrs.2021.105728.","journal-title":"Pharmacol Res"},{"key":"2057_CR66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.phymed.2024.155554","volume":"135","author":"B Zou","year":"2024","unstructured":"Zou B, Long Y, Gao RS, Liu QZ, Tian XF, Liu B, Zhou Q. Nanodelivery system of traditional Chinese medicine bioactive compounds: application in the treatment of prostate cancer. Phytomedicine. 2024;135:9. https:\/\/doi.org\/10.1016\/j.phymed.2024.155554.","journal-title":"Phytomedicine"},{"issue":"5","key":"2057_CR67","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5582\/bst.2021.01318","volume":"15","author":"XY Zhang","year":"2021","unstructured":"Zhang XY, Qiu H, Li CS, Cai PP, Qi FH. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci Trends. 2021;15(5):283\u201398. https:\/\/doi.org\/10.5582\/bst.2021.01318.","journal-title":"Biosci Trends"},{"issue":"8","key":"2057_CR68","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2174\/1874467216666230210091839","volume":"16","author":"S Kiran","year":"2023","unstructured":"Kiran S, Patra A, Verma P, Purkait S, Chhabra G, Guttula PK, Ghosh A. Restoration of altered oncogenic and tumor suppressor Microrna expression in breast cancer and colorectal cancer cell using epicatechin. Curr Mol Pharmacol. 2023;16(8):915\u201326. https:\/\/doi.org\/10.2174\/1874467216666230210091839.","journal-title":"Curr Mol Pharmacol"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02057-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02057-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02057-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:25:50Z","timestamp":1771327550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02057-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2057"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02057-5","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal studies were conducted with the approval of the Institutional Animal Care and Ethics Committee of the Affiliated Changsha Central Hospital, University of South China (No. 2023-ky-131), following both NIH and institutional animal care guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}